Increased IFN-γ secretion that is associated with NK and T cell activation, in concert with delivered IL2 and IL12 is moreover expected to shift the Th2 imbalance in the lymphoma lesion towards Th1 reactivity which might counteract the T cell hypo-responsiveness in Hodgkin's lymphoma. The gene discussed is IFNG; the disease is Hodgkins lymphoma.